NRS South-East Cancer Research Network

Edinburgh, Midlothian EH4 2XR

1 studies enrolling now · 1 studies all time

What they study most

NSCLC Stage IV

Studies at this site

• Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In — Recruiting now